JLJong Dae Lee

Jong Dae Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jong Dae Lee has a total of 175 co-authors. Here are the top co-authors by number of shared publications:

  • Se A Lee

    Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, Korea

    13 shared publications
  • Se A. Lee

    Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, Korea

    7 shared publications
  • Bo Gyung Kim

    6 shared publications
  • In Seok Moon

    Department of Otorhinolaryngology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea

    5 shared publications
  • Hyun Sook Hong

    Department of Radiology, Soonchunhyang University College of Medicine, Bucheon, South Korea

    4 shared publications
  • Bo Gyung Kim

    Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon, Korea

    3 shared publications

Latest Publications

  • Clinical Practice Guideline for the Evaluation and Management of Facial Nerve Palsy

    by Se A Lee, Ho Yun Lee, Min Young Kwak, Jin Kim, Myung Chul Yoo, Young Sang Cho, Junhui Jeong, Sanghoon Kim, Je-Young Shin, Jisang Han, et al.

    To develop evidence-based clinical practice guidelines for evaluating and managing peripheral facial nerve palsy within the Korean healthcare system. A multidisciplinary guideline committee-comprising otolaryngologists, a neurologist, a neurosurgeon, a rehabilitation medicine specialist, an ophthalmologist, a plastic surgeon, and a methodology expert-conducted de novo systematic reviews. Literature searches were performed in MEDLINE, Embase, the Cochrane Library, and KoreaMed through November 30, 2024. Evidence was appraised using the GRADE methodology, and nine key clinical questions (KQs) were formulated using the PICO framework. Recommendations were finalized through structured consensus requiring at least 70% agreement. A patient preference survey (n = 51) informed value considerations. The draft guideline underwent external review by seven independent experts. Ten recommendations addressing nine KQs were developed. The House-Brackmann grading system is recommended as the standard assessment tool (Grade A). Routine testing is unnecessary for typical Bell's palsy; selective testing is advised for atypical features (Grade B). Electrodiagnostic studies may be used for prognostic evaluation in severe cases (Grade B). Oral corticosteroids are strongly recommended within 72 hours of symptom onset (Grade A). Antivirals may be added based on clinical judgment and patient preference (Grade B). Facial nerve decompression may be considered in selected patients with severe degeneration (Grade B). Rehabilitation therapy, surgery for chronic palsy, botulinum toxin injection for synkinesis, and multidisciplinary management are conditionally recommended (Grade B). This guideline provides an evidence-based framework for managing facial nerve palsy in Korea. It integrates systematic evidence, patient preferences, and healthcare system factors, including National Health Insurance coverage and regional accessibility.


  • Open Access

    Values and Preferences of Korean Patients With Facial Palsy: A Cross-Sectional Survey

    by Hye Ah Joo, Jin Kim, Min Young Kwak, Myung Chul Yoo, Young Sang Cho, Se A Lee, Junhui Jeong, Sanghoon Kim, Je-Young Shin, Jisang Han, et al.

    Joo HA, et al. J Korean Med Sci. 2026 Jun;41(24):e166. https://doi.org/10.3346/jkms.2026.41.e166

  • Open Access

    Prevalence and preferred medication for vestibular migraine in Menière’s disease: a multicenter retrospective cohort study in Korea

    by Dong-Han Lee, Hong Ju Park, Kyu-Sung Kim, Jae-Yong Byun, Min-Beom Kim, Minbum Kim, Myung-Whan Suh, Jae-Hyun Seo, Jong Dae Lee, Eun-Ju Jeon, et al.

    Objectives: The aim of this study is to categorize headaches associated with definite Menière’s disease (MD) according to diagnostic criteria, to determine their prevalence, and to investigate the preferred medication across participating centers.Methods: Patients diagnosed with definite MD at 17 university hospitals in otolaryngology or neurology departments in Korea between January 1, 2021 to December 31, 2021 were retrospectively included. Data on the presence of accompanying vestibular migraine (VM), migraine or non-migraine headaches, and clinical information were collected. A survey was conducted to assess preferences for treatment drugs for vertigo and headache control in MD patients with headache.Results: A total of 435 definite MD patients were included, with a mean age of 57.0±14.9 years. Among them, 135 (31.0%) had accompanying headaches, of whom 48 (11.0% of all definite MD patients) could be diagnosed with VM. The prevalence of comorbid VM (definite and probable) was significantly higher in females (41 of 288, 14.2%) than in males (7 of 147, 4.8%) (p 0.05). Benzodiazepines, antihistamines, and antiemetics were mainly preferred for acute vertigo control, while nonsteroidal anti-inflammatory drugs, acetaminophen, and triptans were preferred for acute headache control, and topiramate, propranolol, and calcium channel blockers were mainly preferred for headache prevention.Conclusions: VM is not uncommon in patients with definite MD in Korea. Further research is needed to understand the differences in headache prevalence and preferred medications across different centers.


  • Long-term follow-up results of facial nerve schwannoma with good facial nerve function: a multicenter study

    by Young Sang Cho, Jong Dae Lee, Yang-Sun Cho, Jun Ho Lee, Hee Won Seo, Jang Wook Gwak, In Seok Moon, Jin Woong Choi, Gyu Cheol Han, Ja-Won Koo, et al.

    Purpose Facial nerve schwannomas (FNSs) are rare intracranial tumors, and the optimal management of these tumors remains unclear. We investigated the long-term follow-up results of FNS with good facial nerve function. Methods At nine medical centers in the Korean Facial Nerve Study Group, 43 patients undergoing observation periods longer than 12 months for FNS with good facial nerve function (House-Brackmann grade ≤ II) were enrolled, and clinical and radiographic data were obtained for these cases. Results The mean follow-up period was 63 months. In the majority of cases, tumors involved multiple segments (81.4%) and only eight cases were confined to a single site. There were no cases where the tumor was confined to the extratemporal region. Tumor size increased slightly, with an average estimated change of 0.48 mm/year. Twenty (46.5%) of 43 patients showed no change in tumor size. Seven patients (16.3%) showed worsening House-Brackmann (H–B) grade, of which two patients deteriorated from H–B grade I to II, four worsened to grade III, and one deteriorated to grade IV. The remaining 36 patients (83.7%) showed no change in facial nerve function. There was no difference in H–B grade according to tumor size at the time of diagnosis or change in tumor size. Conclusion We conducted a large-scale observational study of FNS with good facial nerve function. Our study showed that many patients maintained facial nerve function during long-term follow-up. Conservative management with regular examination and imaging can be an appropriate option for managing FNS with good facial nerve function.


  • Tumor shape as a prognostic factor for the growth of intracanalicular vestibular schwannoma: a long-term observational study

    by Se A Lee, Jae Ha Lee, Hyun Sook Hong, Jong Dae Lee

    Purpose To evaluate the predictive factors of tumor growth in patients with vestibular schwannoma (VS) managed with the wait-and-scan approach. Methods The data of 31 patients diagnosed with intracanalicular VS and followed for > 5 years were retrospectively analyzed. VS was diagnosed according to MRI findings and tumor growth was monitored. Tumor growth was defined as an increase of 2 mm or more in the maximal tumor diameter. The association between the initial tumor size and shape and tumor growth was assessed. Results Tumor growth was observed in 16 of 31 patients (51.6%) over a mean follow-up duration of 7.3 years. The initial tumor size was not statistically correlated with tumor growth. However, fusiform or cylindrical tumors exhibited higher growth rates than oval or round tumors. Additionally, a significant correlation was observed between cerebellopontine angle extension and tumor shape. Conclusion In this study, 51.6% of the patients with intracanalicular VS who were managed with the wait-and-scan strategy over a follow-up period of > 5 years showed tumor growth. Tumor shape, especially fusiform or cylindrical shape, was found to be a significant predictor of tumor growth.


  • Open Access

    Clinical characteristics of persistent postural‐perceptual dizziness and its visual subtype in Korean patients: A multicenter cross‐sectional study

    by Joo Hyun Park, Thanh Tin Nguyen, Sung‐Hee Kim, Ji‐Yun Park, Seunghee Na, Eun‐Ju Jeon, Ji Won Seo, Chang Gun Cho, Se‐Joon Oh, Sung‐Won Choi, et al.

    Objectives: Persistent postural‐perceptual dizziness (PPPD) is a chronic functional vestibular disorder for which the Bárány Society has established diagnostic criteria. This nationwide multicenter study aims to investigate the clinical features of individuals with definite PPPD and clinical variant PPPD who do not fully meet the diagnostic criteria, with a particular focus on visual exaggeration.Methods: Between September 2020 and September 2021, a total of 76 individuals with definite PPPD and 109 individuals with clinical variant PPPD who did not meet all three exacerbating factors outlined in Criterion B were recruited from 18 medical centers in South Korea. The study gathered information on demographic factors, clinical manifestations, balance scales, and personality assessments.Results: Comparative analysis between groups with definite PPPD and clinical variant with visual exacerbation revealed no significant differences in sociodemographic characteristics, clinical course, dizziness impact, and specific precipitants. Only disease duration was significantly longer in definite PPPD compared with variant with visual exacerbation. However, the variant without visual exacerbation displayed significantly reduced rates of panic disorder, diminished space‐motion discomfort, lesser impact of dizziness, and decreased prevalence of depression when compared with the definitive PPPD.Conclusion: This is the first comprehensive nationwide study examining clinical features of both definite PPPD patients and its clinical variants, considering visual exacerbating factors. Differences in dizziness and personality traits emerged between definite PPPD and its potential variant without visual issues. Our results highlight the possibility of a distinct clinical variant of PPPD influenced by visual dependency.


  • Open Access

    The Impact of the COVID-19 Pandemic on Bell’s Palsy and Ramsay-Hunt Syndrome: A Multicenter Retrospective Study

    by Min Young Kwak, Ho Yun Lee, Se A Lee, Junhui Jeong, Jae Ho Chung, Jin Kim, Beom Cho Jun, Seung-Geun Yeo, Sang Hoon Kim, Jong Dae Lee

    Kwak MY, et al. J Korean Med Sci. 2024 Apr;39(16):e140. https://doi.org/10.3346/jkms.2024.39.e140


  • Open Access

    Auditory Brainstem Response Data Preprocessing Method for the Automatic Classification of Hearing Loss Patients

    by Jun Ma, Jae-Hyun Seo, Il Joon Moon, Moo Kyun Park, Jong Bin Lee, Hantai Kim, Joong Ho Ahn, Jeong Hun Jang, Jong Dae Lee, Seong Jun Choi, et al.

    Auditory brainstem response (ABR) is the response of the brain stem through the auditory nerve. The ABR test is a method of testing for loss of hearing through electrical signals. Basically, the test is conducted on patients such as the elderly, the disabled, and infants who have difficulty in communication. This test has the advantage of being able to determine the presence or absence of objective hearing loss by brain stem reactions only, without any communication. This paper proposes the image preprocessing process required to construct an efficient graph image data set for deep learning models using auditory brainstem response data. To improve the performance of the deep learning model, we standardized the ABR image data measured on various devices with different forms. In addition, we applied the VGG16 model, a CNN-based deep learning network model developed by a research team at the University of Oxford, using preprocessed ABR data to classify the presence or absence of hearing loss and analyzed the accuracy of the proposed method. This experimental test was performed using 10,000 preprocessed data, and the model was tested with various weights to verify classification learning. Based on the learning results, we believe it is possible to help set the criteria for preprocessing and the learning process in medical graph data, including ABR graph data.